Table 2.

Quantitative determination of UA-lowering activity of the strains.

Strain	Nucleotide degradation rate (%)	Nucleoside degradation rate (%)	Purine degradation rate (%)	Uric acid degradation rate (%)
FN2-39	68.1484 ± 1.9597	76.0759 ± 2.5828	72.6720 ± 1.1685	40.7223 ± 2.5316
J5	92.9175 ± 1.9205	81.1367 ± 4.7229	57.7971 ± 5.0708	44.4617 ± 0.7307
M3-2-1	64.5186 ± 5.0598	79.4009 ± 1.1137	66.2683 ± 0.5522	21.0915 ± 9.9491
FN518	80.2143 ± 1.6908	79.2538 ± 1.1992	67.8075 ± 2.8154	57.0609 ± 2.3926
KV9	87.3277 ± 4.7697	85.7095 ± 4.4631	69.3296 ± 6.8912	28.0097 ± 1.9478
MDHXM	92.5765 ± 0.1819	89.4102 ± 1.9665	66.8331 ± 2.1358	6.9196 ± 4.0219
X11	99.9965 ± 0.0011	99.9987 ± 0.0023	83.2462 ± 0.9644	80.4153 ± 1.8229
K11	70.1502 ± 5.0934	88.5926 ± 4.9378	76.6868 ± 0.4113	42.2661 ± 3.1298
YR3115	37.2716 ± 2.1795	81.5065 ± 3.1096	73.3516 ± 2.2941	38.8039 ± 2.9163
F1-7	76.6291 ± 8.3031	82.7201 ± 4.5419	60.6868 ± 2.4632	29.2897 ± 3.0150
MN45	58.2545 ± 0.1023	64.7772 ± 3.1109	64.8054 ± 0.6875	50.5192 ± 2.9395
F27-3	69.2139 ± 8.1247	68.1975 ± 6.9705	36.5312 ± 1.3944	49.1143 ± 3.7025
MN20	48.4488 ± 2.3413	45.1674 ± 1.5165	58.0608 ± 4.3048	57.3631 ± 2.6593
YZX-21	73.3027 ± 2.2671	65.6776 ± 1.8260	52.7699 ± 2.8804	41.8382 ± 1.5089
1F-6	71.7534 ± 2.4152	79.8313 ± 1.3130	18.8075 ± 6.2836	26.3679 ± 2.2030
MFGSQ	76.2463 ± 0.0179	80.2348 ± 1.5708	38.3278 ± 8.9261	-6.5966 ± 5.1704
L-577	70.6311 ± 8.4608	78.9717 ± 2.0439	68.8700 ± 2.2448	34.8002 ± 4.8300
LGG	73.2782 ± 0.7263	79.8248 ± 1.0010	58.1199 ± 4.8671	26.9346 ± 1.3504
YZX-38	78.3186 ± 8.5527	78.8045 ± 1.1141	67.4593 ± 2.1933	32.7707 ± 3.8295
F1-3-2	72.8688 ± 0.5476	77.4971 ± 8.4655	12.1073 ± 1.0656	15.9451 ± 2.5814
FN2-39	68.1484 ± 1.9597	76.0759 ± 2.5828	72.6720 ± 1.1685	40.7223 ± 2.5316
J5	92.9175 ± 1.9205	81.1367 ± 4.7229	57.7971 ± 5.0708	44.4617 ± 0.7307
M3-2-1	64.5186 ± 5.0598	79.4009 ± 1.1137	66.2683 ± 0.5522	21.0915 ± 9.9491

UA, uric acid.